Consortium for Imaging and Biomarkers (CIB)

An MRI of a breast.Overdiagnosis and false positives present significant clinical problems in the prevention, detection and treatment of cancer. Therefore, there is an unmet clinical need to more accurately identify early-stage aggressive cancers and distinguish lesions that are life threatening from those that are not. The Consortium for Imaging and Biomarkers (CIB) seeks to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk, and cancer diagnosis by integrating imaging strategies with biomarkers into complementary approaches.

Read more About CIB

Members of CIB

  • Beckman Research Institute
  • Boston University
  • Fred Hutchinson Cancer Center
  • Houston Methodist Research Institute
  • Rice University
  • Rush University Medical Center
  • University of Miami
  • University of Michigan
  • University of North Carolina
  • University of Texas MD Anderson
  • University of Washington
  • University of Wisconsin-Madison
  • Vanderbilt University

More about the Members of CIB

News and Events

Annual Meeting
2019 to be announced

Next Webinars
Date: Monday, October 22, 2018
Date: Monday, November 19, 2018
Date: Monday, December 17, 2018

See News and Events

Funding Opportunity

One new FOA is open for application: Imaging and Biomarkers for Early Detection of Aggressive Cancer (U01) PAR-16-089

Application due dates: July 10, 2018 and December 11, 2018